Opinion

Video

Understanding Myelodysplastic Syndromes (MDS): Diagnosis, Classification, and Risk Assessment

Panelists discuss how myelodysplastic syndromes are diagnosed, classified, and managed, covering prevalence, symptoms, risk stratification tools, prognosis for lower-risk cases, and current treatment challenges.

  • To start our conversation, how prevalent is MDS? What are common symptoms patients may present with?
  • Can you share how you diagnose and classify MDS?
    • Please comment on common differential diagnoses & tests typically used for MDS diagnosis.
  • Please comment on the risk stratification tools IPSS-M and if you have adapted using this stratification tool in your practice.
  • What do you are share to your patients in terms of prognosis for those with lower-risk MDS?
  • What are some current challenges for treating lower-risk MDS?
Related Videos
5 KOLs are featured in this series.
5 KOLs are featured in this series.
A panel of 3 experts on nasopharyngeal carcinoma
A panel of 3 experts on nasopharyngeal carcinoma
A panel of 3 experts on nasopharyngeal carcinoma
Robert Z. Orlowski, MD, PhD, and Jonathan Kaufman, MD
Related Content